MOLNUPIRAVIR
New COVID-19 Guidelines: Antibiotics Shouldn't Be Used in COVID-19 Unless Suspicion of Bacterial Infection, Says Central Govt
Indian-Origin Scientist Discovers New Omicron Subvariant Resistant to All Known Antibody Therapies
Laurus Labs Inks Pact With Geneva-Based MPP To Produce Oral COVID-19 Antiviral Medication Molnupiravir
COVID-19 Treatment Update: Don't Use Molnupiravir for Treating Coronavirus in Younger Population, Warns Dr NK Arora
Lupin Launches Antiviral Medication Molnupiravir Under Brand 'Molnulup' for COVID-19 Treatment in Adults
Molnupiravir, COVID-19 Antiviral Drug, Launched in India at Rs 1,399 For Mild to Moderate Infection
Molnupiravir Capsules: Dr Reddy's Laboratories Gets DCGI's Nod to Launch Oral Anti-Viral Drug in India For Treatment of Adult Patients With COVID-19
Corbevax, Covovax, Anti-Viral Drug Molnupiravir Approved by Drug Regulator CDSCO In Fight Against COVID-19
Govt Panel Recommends Emergency Use Authorisation for Covovax, Corbevax and Anti-COVID-19 Pill Molnupiravir
Sun Pharma to Introduce MSD, Ridgeback's Molnupiravir Under Brand 'Molxvir' in India For COVID-19 Treatment in Adults; DCGI Reviewing Clinical Data
COVID-19 Drug Molnupiravir May Reduce Risk of Hospitalisation and Death in Newly-Diagnosed Patients, Says Health Expert Dr Krishna Reddy Nallamalla
Google Trends